Abstract:Background: The pathological effects of beta amyloid; oligomers may be mediated through the metabotropic glutamate receptor subtype 5 (mGluR5), leading to synaptic loss in Alzheimer's disease (AD). Positron emission tomography (PET) studies of mGluR5 using [18F]FPEB indicate a reduction of receptor binding that is focused in the medial temporal lobe in AD. Synaptic loss due to AD measured through synaptic vesicle glycoprotein 2A (SV2A) quantification with [11C]UCB_J PET is also focused in the medial temporal lobe, but with clear widespread reductions is commonly AD affected neocortical regions. In this study, we used [18F]FPEB and [11C]UCB_J PET to investigate the relationship between mGluR5 and synaptic density in early AD. Methods: Fifteen amyloid positive participants with early AD and 12 amyloid negative, cognitively normal (CN) participants underwent PET scans with both [18F]FPEB to measure mGluR5 and [11C]UCB_J to measure synaptic density. Parametric DVR images using equilibrium methods were generated from dynamic. For [18F]FPEB PET, DVR was calculated using equilibrium methods and a cerebellum reference region. For [11C]UCB_J PET, DVR was calculated with a simplified reference tissue model _ 2 and a whole cerebellum reference region. Result: A strong positive correlation between mGluR5 and synaptic density was present in the hippocampus for participants with AD (r = 0.81, p < 0.001) and in the CN group (r = 0.74, p = 0.005). In the entorhinal cortex, there was a strong positive correlation between mGluR5 and synaptic in the AD group (r = 0.85, p <0.001), but a weaker non-significant correlation in the CN group (r = 0.36, p = 0.245). Exploratory analyses within and between other brain regions suggested significant positive correlations between mGluR5 in the medial temporal lobe and synaptic density in a broader set of commonly AD_affected regions. Conclusion: Medial temporal loss of mGluR5 in AD is associated with synaptic loss in both medial temporal regions and more broadly in association cortical regions, indicating that mGluR5 mediated amyloid beta oligomers toxicity may lead to early synaptic loss more broadly in AD_affected networks. In CN individuals, an isolated strong association between lower mGluR5 and lower synaptic density may indicate non_AD related synaptic loss.

Upregulated excitatory amino acid transporter 1 (EAAT1) expression in the human medial temporal lobe in Alzheimer's disease

Astrocytic proteins involved in regulation of the extracellular environment are increased in the Alzheimer's disease middle temporal gyrus

Impaired expression of GABA transporters in the human Alzheimer’s disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus

Alzheimer's disease-associated region-specific decrease of vesicular glutamate transporter immunoreactivity in the medial temporal lobe and superior temporal gyrus

Aberrant Expression of the Pore-Forming KATP Channel Subunit Kir6.2 in Hippocampal Reactive Astrocytes in the 3Xtg-Ad Mouse Model and Human Alzheimer's Disease.

Alzheimer’s Disease Enhanced Tonic Inhibition is Correlated With Upregulated Astrocyte GABA Transporter-3/4 in a Knock-In APP Mouse Model

Increased MANF Expression in the Inferior Temporal Gyrus in Patients With Alzheimer Disease

[Okadaic Acid Induces the Expression of Glutamate Transporter EAAT1 in the Neurons of Rat Brain].

Reduced uptake of [11C]‐ABP688, a PET tracer for metabolic glutamate receptor 5 in hippocampus and amygdala in Alzheimer’s dementia

Proteomic and Transcriptomic Analyses Reveal Pathological Changes in the Entorhinal Cortex Region that Correlate Well with Dysregulation of Ion Transport in Patients with Alzheimer’s Disease

Expression of SLC25A18 is positively correlated with Alzheimer's disease

Increased Expression of SLC25A18 is Associated with Alzheimer’s Disease and is Involved in Aβ42-induced Mitochondrial Dysfunction and Apoptosis in Neuronal Cells

Impaired Eukaryotic Elongation Factor 1A Expression in Alzheimer's Disease.

A Medicinal Chemistry Perspective on Excitatory Amino Acid Transporter 2 Dysfunction in Neurodegenerative Diseases

Amyloid induced hyperexcitability in default mode network drives medial temporal hyperactivity and early tau accumulation

Upregulation of endocytic protein expression in the Alzheimer's disease male human brain

A postmortem study of amino acid neurotransmitters in Alzheimer's disease

Assessment of the relationship between synaptic density and metabotropic glutamate receptors in early Alzheimer's disease: a multi-tracer PET study

Aβ-mediated synaptic glutamate dynamics and calcium dynamics in astrocytes associated with Alzheimer's disease

Longitudinal markers of cerebral amyloid angiopathy and related inflammation in rTg-DI rats

Age-Dependent Shift of AMPA Receptors From Synapses to Intracellular Compartments in Alzheimer's Disease: Immunocytochemical Analysis of the CA1 Hippocampal Region in APP/PS1 Transgenic Mouse Model